Cited by 541Advanced Causal Inference TechniquesStatistical Methods in EpidemiologyStatistical Methods in Clinical Trials

Indications for propensity scores and review of their use in pharmacoepidemiology

Open access
Glynn, Robert J., Schneeweiss, Sebastian, Stürmer, Til·2006·Basic & Clinical Pharmacology & Toxicology

Abstract

Abstract: Use of propensity scores to identify and control for confounding in observational studies that relate medications to outcomes has increased substantially in recent years. However, it remains unclear whether, and if so when, use of propensity scores provides estimates of drug effects that are less biased than those obtained from conventional multivariate models. In the great majority of published studies that have used both approaches, estimated effects from propensity score and regression methods have been similar. Simulation studies further suggest comparable performance of the two approaches in many settings. We discuss five reasons that favour use of propensity scores: the value of focus on indications for drug use; optimal matching strategies from alternative designs; improved control of confounding with scarce outcomes; ability to identify interactions between propensity of treatment and drug effects on outcomes; and correction for unobserved confounders via propensity score calibration. We describe alternative approaches to estimate and implement propensity scores and the limitations of the C‐statistic for evaluation. Use of propensity scores will not correct biases from unmeasured confounders, but can aid in understanding determinants of drug use and lead to improved estimates of drug effects in some settings.

Integrity signals

Registry

Crossref · 10.1111/j.1742-7843.2006.pto_293.x

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Risk stratification can control observed confounders more efficiently than regression and may outperform propensity scores when covariates are weakly correlated with exposure.

    “These methods constitute a broader strategy of risk stratification, allowing for more efficient control of observed confounders than regression-based approaches [31,32], and are a better alternative to propensity score estimation when covariates are not highly correlated with the exposure [33].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Glynn, R. J., Schneeweiss, S., & Stürmer, T.
Affiliations
Brigham and Women's Hospital (US)
Corresponding author
Glynn, Robert J.
Venue
Basic & Clinical Pharmacology & Toxicology
Publisher
Wiley
Published
2006-03
Volume
98
Issue
3
Pages
253-259
ISSN
  • 1742-7835 (ISSN-L)
  • 1742-7843
OpenAlex
W2073225472
Cited by
541
References
32
Citations by year
2026: 8 · 2025: 11 · 2024: 15 · 2023: 19 · 2022: 29 · 2021: 29 · 2020: 33 · 2019: 43 · 2018: 36 · 2017: 33 · 2016: 41 · 2015: 37 · 2014: 35 · 2013: 43 · 2012: 35
FWCI
2.80
Type
journal article
Language
en
Open access
Locations
  • Basic & Clinical Pharmacology & Toxicology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute on Aging (AG-18833, R56AG023178, AG-23178, R56AG018833, R01AG018833, R01AG023178)
Topics
  • Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Keywords
propensity score, pharmacoepidemiology, confounding adjustment, observational studies, propensity score matching, unmeasured confounding, concordance index, simulation study
MeSH terms
Clinical Trials as Topic, Data Interpretation, Statistical, Humans, Research Design, Models, Statistical, Bias, Confounding Factors, Epidemiologic, Treatment Outcome, Outcome Assessment, Health Care, Pharmacoepidemiology, Drug-Related Side Effects and Adverse Reactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review